Drug Trial Radar · NCT06542874
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
448
Actual
Start
Aug 7, 2024
Primary completion
Oct 1, 2025
Study completion Oct 24, 2025
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Participants will either get NNC0487-0111, which is given as tablets or as injections, or placebo. Which treatment the participant get is decided by chance.The study will last for about 43 weeks.
Conditions
- Type 2 Diabetes (T2D)
Interventions
NNC0487-0111 subcutanousDrug
NNC0487-0111 administered subcutanously (under the skin)
Placebo (NNC0487-0111 subcutanous)Drug
NNC0487-0111 placebo administered subcutanously (under the skin)
NNC0487-0111 oralDrug
NNC0487-0111 administered orally (in the mouth)
Placebo (NNC0487-0111 oral)Drug
NNC0487-0111 placebo administered orally (in the mouth)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in HbA1cTime frame: From baseline (week 0) to end of treatment (week 36)
Locations
137 sites in 11 countries. Site status is shown where the registry gives one.
Uni of Alabama at Birmingham
Birmingham, Alabama
Velocity Clin Research LA
Los Angeles, California
Southern Cal Clinical Research
Santa Ana, California
Chase Medical Research LLC
Waterbury, Connecticut
Fleming Island Ctr for Clin Res
Fleming Island, Florida
Encore Medical Research LLC
Hollywood, Florida
South Broward Research LLC
Miramar, Florida
Florida Inst For Clin Res
Orlando, Florida
Florida Institute for Clinical research
Orlando, Florida
Cedar-Crosse Research Center
Chicago, Illinois
Cotton O'Neil Clinical Research Center
Topeka, Kansas
Advanced Internal Medicine, PLLC
Paducah, Kentucky
Medstar Research Institute_Hyattsville
Hyattsville, Maryland
MD Medical Research
Oxon Hill, Maryland
Brigham & Women's Hospital
Boston, Massachusetts
ActivMed Practice & Research LLC
Methuen, Massachusetts
Arcturus HC PLC Troy Med Res
Troy, Michigan
Arcturus Healthcare, PLC
Troy, Michigan
Clinical Research Professionals
Chesterfield, Missouri
StudyMetrix Research LLC
City of Saint Peters, Missouri
AMC Community Endocrinology
Albany, New York
Centricity Rsrch MHCity Multi
Morehead City, North Carolina
Piedmont Healthcare/Research
Statesville, North Carolina
Lillestol Research LLC
Fargo, North Dakota
Plains Clinical Research Center, LLC_Fargo
Fargo, North Dakota
Alliance for Multispec Res
Norman, Oklahoma
Jefferson Endocrinology Assocs
Philadelphia, Pennsylvania
Preferred Primary Care Physicians_Pittsburgh
Pittsburgh, Pennsylvania
Health Concepts
Rapid City, South Dakota
Holston Medical Group
Kingsport, Tennessee
Clinical Research Associates
Nashville, Tennessee
MidState Endocrine Associates
Nashville, Tennessee
Velocity Clinical Res-Dallas
Dallas, Texas
Victorium Clinical Research
Houston, Texas
Synergy Groups Medical
Houston, Texas
PlanIt Research, PLLC
Houston, Texas
Radiance Clinical Research
Lampasas, Texas
Tekton Research
McKinney, Texas
Hillcrest Family Health Center
Waco, Texas
Individual Practice For Specialized Outpatient Medical Care Doctor Miglena Rizova Ltd.
Kyustendil, Bulgaria
Showing 40 of 137 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.